Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Interventional × Yttrium-90 × Clear all

Phase

Phase NA 6 Phase 2 6 Phase 1 5 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Liver Neoplasms 1 Carcinoma, Hepatocellular 1

Interventions

pembrolizumab 340 Cyclophosphamide 332 Carboplatin 267 Gemcitabine 241 Paclitaxel 238 Nivolumab 225 Cisplatin 208 Radiotherapy 187 Bevacizumab 174 fludarabine 162 Dexamethasone 161 Docetaxel 160 Rituximab 153 Capecitabine 142 Lenalidomide 129 Oxaliplatin 128 Fluorouracil 122 Temozolomide 117 Cytarabine 113 Irinotecan 109 Cetuximab 109 Etoposide 108 venetoclax 104 fludarabine phosphate 104 Doxorubicin 96 130-nm albumin-bound paclitaxel 95 Injections 94 Azacitidine 93 Ipilimumab 92 Pemetrexed 89

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06725121 2024-12-16

MacroTrans

University Health Network, Toronto

Phase 1/2 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡